Anagen effluvium is a form of hair loss that occurs during the anagen, or growth, phase of the hair cycle. This condition is often triggered by factors such as chemotherapy, radiation therapy, or severe stress, leading to rapid shedding of hair. Unlike telogen effluvium, which affects hair follicles that are resting, anagen effluvium directly impacts active hair follicles, resulting in more pronounced and immediate hair loss. Patients may notice hair thinning or bald patches, particularly on the scalp. Treatment focuses on addressing the underlying cause and may include supportive therapies like scalp cooling to minimize hair loss during chemotherapy. Understanding anagen effluvium is crucial for dermatologists and cosmetologists, as timely intervention can help manage the emotional and aesthetic challenges associated with this condition.
Sergei A Grando
University of California Irvine, United States
Gustavo Hector Leibaschoff
World Society of Cosmetic Gynecology, United States
Nalini Kaul
Princeton Consumer Research, Canada
Dechelette Corinne
La Peau Autrement, France
Rachita Dhurat
LTMMC & LTMG Hospital, India
Frederick H Silver
Robert Wood Johnson Medical School, Rutgers University, United States
Daan Thorn Leeson
Rodan + Fields, United States
Brannon Claytor
Claytor Noone Plastic Surgery, United States
Katie L Frederickson
Meharry Medical College, United States
Xiaozhun Hang
Queensland Institute of Medical Research Berghofer, AustraliaSubmit your abstract Today
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Global perspectives on skin health: Diversity in dermatology and cosmetology
Dave Ray, Dave Ray Enterprises., United States
Title : How to correct cosmetic procedures gone wrong
Bharti Magoo, Golden Touch Clinic, India
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : Efficacy and safety of rituximab versus pulse therapy in immunobullous disorders: A retrospective study
Ravi M Rathod, KMCRI, India
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Stem cells in dermatology and cosmetology
Makoto Senoo, Cell Exosome Therapeutics Inc, Japan
Title : Standards, education and application of special cosmetic treatments in cosmetology practice
Elizabeta Popova Ramova, University MIT Skopje, Macedonia, The Former Yugoslav Republic of